New Activity Packs

Take a look at our amazing new Kids Activity range on our online shop to gift to a child with neuroblastoma.

Specially curated to provide repeat play value, these high quality Packs will help provide entertainment and distraction during the many hours spent in hospital, or at home in isolation.

Our activity selection includes jigsaws, great card games and craft and colouring in sheets for ages from 3 to 8 years. You can entertain the children whilst supporting research for a cure for vulnerable children diagnosed with neuroblastoma.

A huge thank you to Hey Doodle for donation twenty of their delightful wipe-clean and reuse colouring sets.

Gifts that give back

Looking for a gorgeous gift for the little one in your life? Take a look at our gorgeous Jelly Cat range of soft toys available now through our Neuroblastoma Australia online shop.

Your purchases contribute to research into the children's cancer neuroblastoma; a disease that takes the lives of more children under the age of five than any other cancer. To find out more about the promising research projects our supporters have made happen visit our current projects page or our last annual report.

Thank you for your support.

Give a gift to a child with cancer

Brighten a child's day - for as little as $59, you can gift a child with neuroblastoma a fun Activity Pack to keep them entertained and engaged whilst isolated indoors at home or in hospital.

Latest

Golf2Cure 2024

Golf2Cure 2024 will take place on Friday, September 6. We're returning to the hugely popular St Michael’s Golf Club, Little Bay to raise vital funds for research into neuroblastoma childhood cancer. Book your spot today!
Eli's Pit Crew

Our son Eli was diagnosed with stage four neuroblastoma in July 2023, at the young age of nine months.After a traumatic start to his diagnosis which placed him in life threatening condition, Eli survived four courses of chemotherapy and numerous health complications.
Call to Federal Government for equitable access to DFMO

DFMO (eflornithine) was approved in December 2023 by FDA for treatment of high-risk neuroblastoma as a maintenance therapy to reduce the risk of relapse
Jackson's Story

Shortly before his first birthday, Jackon's family noticed he had developed a limp in his right leg. Further tests revealed Jackson had neuroblastoma. His dad, Andrew, shares their story.